Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLINICAL STUDY PROTOCOL for the Prospective Evaluation of the fluID Rapid Influenza Test

NCT00826709 is registered in ClinicalTrials.gov with Nanogen, Inc. as lead sponsor.

NCT NCT00826709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00826709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLINICAL STUDY PROTOCOL for the Prospective Evaluation of the fluID Rapid Influenza Test
Lead sponsor
Nanogen, Inc.
Phase
Phase 3
Overall status
Suspended
Start date
February 28, 2009
Completion date
Not reported
Enrollment
1,300 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

influenza